BeOne Medicines AG

ONC

Market cap$32.14 B

Rank#444

SEC filings1,167

BeOne Medicines AG trades as ONC and has a market capitalization of $32.14 B, making it the #444 largest US-listed company by market value. In its fiscal 2025 annual report the company posted revenue of $5.34B, up 40.2% from the prior year and net income of $286.93M. This page tracks BeOne Medicines AG through 1,167 SEC filings, with financial statements and metrics updated as new reports are filed.

Key metrics

Revenue (latest FY)$5.34BFY 2025

Net income (latest FY)$286.93MFY 2025

Operating cash flow (latest FY)$1.13BFY 2025

Total assets (latest FY)$8.19BFY 2025

Gross margin87.5%latest FY

Net margin5.4%latest FY

Financial performance

Over the last 9 fiscal years BeOne Medicines AG's revenue grew from $1.07M to $5.34B, a compound annual growth rate of 157.6%. Net profit margin expanded from -11141.8% to 5.4% over the same period - every figure below comes from the company's audited annual filings.

ONC annual revenueView details

Key statistics

Market cap: $32.14 B
Share price (derived)market cap / shares outstanding: $22.24
P/E ratio (trailing FY): 112.0
EPS (diluted)FY 2025: $0.19
Shares outstandingas of 2026-04-30: 1.45B
Total equityas of 2026-03-31: $4.76B
Return on equity: 6.0%
Long-term debtas of 2026-03-31: $842.92M

Latest filings

Filing	Type	Filed
Insider sale notice	144	2026-05-22
Insider sale notice	144	2026-05-22
Insider sale notice	144	2026-05-22
Insider sale notice	144	2026-05-22
Insider sale notice	144	2026-05-22
Insider trade	4	2026-05-15
Major company event	8-K	2026-05-15
3/A	-	2026-05-15

Browse the full filing history (1,167 filings)

Recent press releases

Streamline Health® Reports Fiscal First Quarter 2025 Financial ...
Total revenue for the first quarter of fiscal 2025 increased approximately 12% to $4.8 million as compared to $4.3 million during the first quarter of fiscal ...
Streamline Health Names Thomas J. Gibson Senior Vice President ...
Mr. Gibson, 55, is the former Chief Financial Officer of Citra Health Solutions and Vivex Biomedical, Inc.
MDaudit and Streamline Health Announce Definitive Merger ...
MDaudit will acquire all outstanding shares of Streamline stock for $5.34 per share in cash, which represents a premium of 138% to Streamline's closing price.

Similar companies

The largest companies sharing BeOne Medicines AG's SEC industry classification (pharmaceutical preparations).

LLYEli Lilly and Company$1.072 T ONC vs LLY

JNJJohnson & Johnson$573.98 B ONC vs JNJ

ABBVAbbVie Inc.$399.47 B ONC vs ABBV

MRKMerck & Co., Inc.$293.16 B ONC vs MRK

AZNAstraZeneca PLC$286.27 B ONC vs AZN

Frequently asked questions

What is BeOne Medicines AG's market cap?

BeOne Medicines AG (ONC) has a market capitalization of $32.14 B as of 2026-05-29, ranking #444 among US-listed companies.

How much revenue does BeOne Medicines AG make?

BeOne Medicines AG reported revenue of $5.34B for fiscal year 2025, an increase of 40.2% year over year.

Is BeOne Medicines AG profitable?

Yes. BeOne Medicines AG reported net income of $286.93M in its latest fiscal year.

Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.